WeVote
Log In

Bill

Bill

SR 1802

Tardive Dyskinesia Awareness Week

2026 Regular Session Introduced by Ana Maria Rodriguez

Florida designates Tardive Dyskinesia Awareness Week to increase public recognition of this medication-related involuntary movement disorder and its health impacts.

Adopted
#(adopted)
0
WeVote Research Nonpartisan
Bill Summary · SR 1802

Legislative bill overview

SR 1802 designates a specific week in Florida as Tardive Dyskinesia Awareness Week to increase public recognition of this involuntary movement disorder, which can develop as a side effect of certain psychiatric medications. The resolution calls for heightened educational outreach and acknowledgment of the condition's impact on affected individuals.

Why is this important

Tardive dyskinesia (TD) is a serious condition affecting thousands of Floridians, particularly those with psychiatric conditions on long-term antipsychotic medications. Awareness initiatives can help patients and healthcare providers recognize symptoms earlier, encourage informed medication discussions, and reduce stigma around the disorder, potentially leading to better treatment outcomes and medication management practices.

Potential points of contention

  • Resource allocation concerns: Critics may question whether symbolic resolutions represent appropriate use of legislative time when healthcare funding and mental health services face budget constraints
  • Pharmaceutical industry implications: The resolution could be perceived as favorable to patient advocacy groups or medication safety campaigns, raising questions about balance in discussing medication risks versus benefits
  • Limited enforcement mechanism: As a resolution rather than legislation, it carries no binding requirements for funding, education programs, or healthcare provider training, limiting tangible policy impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.